EcoDrugPlus

Tubulin Alpha Chain, Testis-Specific

Ensembl ID : ENSELUG00000004610
Gene Symbol: LOC105015227
2 Cross references
217 Possible Orthologues:

Tubulin Alpha-1b Chain-Like

Ensembl ID : ENSELUG00000006681
Gene Symbol: LOC105013645
2 Cross references
178 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSELUG00000010664
Gene Symbol: TUBB3
4 Cross references
158 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSELUG00000020007
Gene Symbol: TUBB4B
1 Cross references
137 Possible Orthologues:

Tubulin Beta-5 Chain

Ensembl ID : ENSELUG00000027939
Gene Symbol: LOC105028291
3 Cross references
141 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSELUG00000014436
Gene Symbol: TP53
3 Cross references
231 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSELUG00000011493
Gene Symbol: TYR
3 Cross references
203 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSELUG00000020767
Gene Symbol: TYR
4 Cross references
197 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSELUG00000022747
Gene Symbol: TH
3 Cross references
188 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSELUG00000023410
Gene Symbol: TYK2
1 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSELUG00000021380
Gene Symbol: TIE1
3 Cross references
207 Possible Orthologues:

Tyrosine-Protein Kinase Frk

Ensembl ID : ENSELUG00000003316
Gene Symbol: LOC105009089
2 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).